• Home
  •  > 
  • Publications

Publications

To receive a copy of the following publications please contact us

  • Randomized comparison of the Nobori® Biolimus A9-eluting stent with the sirolimus-eluting stent in patients with stenosis in native coronary arteries.

    Kadota, K., Muramatsu, T., Iwabuchi, M., Saito, S., Hayashi, Y., Ikari, Y., Nanto, S., Fujii, K., Inoue, N., Namiki, A., Kimura, T. and Mitsudo, K. (2011)
    Catheterization and Cardiovascular Interventions. doi: 10.1002/ccd.23280

  • Nobori Drug Eluting Stent system – Clinical Evidence Update.

    Gian Battista Danzi, Bernard Chevalier, Miodrag Ostojic, Michalis Hamilos, William Wijns.
    Minerva Cardioangiologica Vol 58, N°5, Pages 599-610 October 2010

  • Comparison of pharmacokinetics of the limus-eluting stents in japanese patients.

    Yoritaka Otsuka, Shigeru Saito, Masato Nakamura, Hideo Shuto and Kazuaki Mitsudo
    Catheterization and Cardiovascular Interventions 2011 Apr 28. doi: 10.1002/ccd.23096

  • Randomized comparison of the Nobori® Biolimus A9-eluting coronary stent with the Taxus® Liberté® paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the NOBORI 1 trial--Phase 2.

    Chevalier B, Silber S, Park SJ, Garcia E, Schuler G, Suryapranata H, Koolen J, Hauptmann KE, Wijns W, Morice MC, Carrie D, van Es GA, Nagai H, Detiege D, Paunovic D, Serruys PW; NOBORI 1 Clinical Investigators.
    Circ Cardiovasc Interv. 2009 Jun;2(3):188-95.
    Epub 2009 May 8.PMID: 20031715 [PubMed - indexed for MEDLINE]

  • Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses.

    Hamilos M, Sarma J, Ostojic M, Cuisset T, Sarno G, Melikian N, Ntalianis A, Muller O, Barbato E, Beleslin B, Sagic D, De Bruyne B, Bartunek J, Wijns W.
    Circ Cardiovasc Interv. 2008 Dec;1(3):193-200.PMID: 20031678 [PubMed - indexed for MEDLINE]

  • The pharmacokinetics of Biolimus A9™ after elution from the Nobori® stent in patients with coronary artery disease: the NOBORI PK study.

    Ostojic M, Sagic D, Jung R, Zhang YL, Nedeljkovic M, Mangovski L, Stojkovic S, Debeljacki D, Colic M, Beleslin B, Milosavljevic B, Orlic D, Topic D, Karanovic N, Paunovic D, Christians U; NOBORI PK Investigators.
    Catheter Cardiovasc Interv. 2008 Dec 1;72(7):901-8.PMID: 19016466 [PubMed - indexed for MEDLINE]

  • Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion.

    Hamilos MI, Ostojic M, Beleslin B, Sagic D, Mangovski L, Stojkovic S, Nedeljkovic M, Orlic D, Milosavljevic B, Topic D, Karanovic N, Wijns W; NOBORI CORE Investigators.
    J Am Coll Cardiol. 2008 Jun 3;51(22):2123-9.PMID: 18510958 [PubMed - indexed for MEDLINE]

  • First clinical comparison of Nobori®-Biolimus A9™ eluting stents with Cypher®-Sirolimus eluting stents: Nobori Core nine months angiographic and one year clinical outcomes.

    Ostojic M, Sagic D, Beleslin B, Jung R, Perisic Z, Jagic N, Nedeljkovic M, Mangovski L, Milosavljevic B, Stojkovic S, Orlic D, Antonic Z, Miloradovic V, Topic D, Paunovic D.
    EuroIntervention. 2008 Mar;3(5):574-9.PMID: 19608483 [PubMed - in process]

  • Randomised comparison of Nobori®, Biolimus A9™-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial.

    Chevalier B, Serruys PW, Silber S, Garcia E, Suryapranata H, Hauptmann K, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D.
    EuroIntervention. 2007 Feb;2(4):426-34.PMID: 19755281 [PubMed - in process]